Details for New Drug Application (NDA): 212645
✉ Email this page to a colleague
The generic ingredient in PAROXETINE HYDROCHLORIDE is paroxetine hydrochloride. There are thirty drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the paroxetine hydrochloride profile page.
Summary for 212645
Tradename: | PAROXETINE HYDROCHLORIDE |
Applicant: | Cadila Pharms Ltd |
Ingredient: | paroxetine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 212645
Mechanism of Action | Serotonin Uptake Inhibitors |
Suppliers and Packaging for NDA: 212645
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PAROXETINE HYDROCHLORIDE | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 212645 | ANDA | Cadila Pharmaceuticals Limited | 71209-094 | 71209-094-01 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71209-094-01) |
PAROXETINE HYDROCHLORIDE | paroxetine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 212645 | ANDA | Cadila Pharmaceuticals Limited | 71209-094 | 71209-094-10 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71209-094-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 12.5MG BASE | ||||
Approval Date: | Aug 27, 2021 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 25MG BASE | ||||
Approval Date: | Aug 27, 2021 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | EQ 37.5MG BASE | ||||
Approval Date: | Aug 27, 2021 | TE: | AB | RLD: | No |
Complete Access Available with Subscription